Arman Oruc > Goodwin > Silicon Valley, United States > Lawyer Profile
Goodwin Offices
601 Marshall Street
Redwood City, CA 94063
CALIFORNIA
United States
Arman Oruc

Position
Partner
Career
Arman Oruc is co-chair of the firm’s Antitrust and Competition practice. He specializes in antitrust related issues, including regulatory clearance and approval of mergers and acquisitions, government investigations, antitrust litigation, and antitrust risks associated with strategic business practices. Arman was most recently part of the founding team of a life sciences company, helping grow the start-up into a late-stage clinical platform company. Arman’s experience in both merger clearance and antitrust litigation, combined with his in-house experience, gives him a unique perspective in his practice.
Education
JD, University of California, Berkeley 1996 / MA, Cambridge University 1993 / BA, Skidmore College 1992
Lawyer Rankings
United States > Antitrust > Merger control
Praised for its ability to provide ‘timely and clear advice under complex circumstances’, the Goodwin antitrust and competition team leverages the firm’s M&A market strength to support clients with HSR filings and sophisticated antitrust challenges. Private equity, technology, and life sciences transactions are particular areas of focus for the team, which has growing expertise regarding AI technologies. Antitrust co-head Andrew Lacy advises clients on transaction-related antitrust risk, working alongside co-chair Arman Oruc whose combined experience in merger clearance and antitrust litigation is notable. Paul Jin and Simone Waterbury together lead the merger control practice, Jin a particular go-to for private equity clients while Waterbury, in Boston, regularly handles cross-border deals. The team was bolstered in July 2024 by the addition of David Cross and Mary Kaiser, both from Morrison Foerster. All Attorneys are based in Washington DC unless otherwise stated.
Lawyer Rankings
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation